Vericel Corp (VCEL)
45.45
-0.66
(-1.43%)
USD |
NASDAQ |
Apr 25, 16:00
45.44
-0.02
(-0.03%)
After-Hours: 20:00
Vericel Profit Margin (Quarterly): 19.99% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.99% |
| September 30, 2023 | -8.03% |
| June 30, 2023 | -10.93% |
| March 31, 2023 | -18.27% |
| December 31, 2022 | 11.24% |
| September 30, 2022 | -17.06% |
| June 30, 2022 | -24.19% |
| March 31, 2022 | -19.66% |
| December 31, 2021 | 9.53% |
| September 30, 2021 | -14.29% |
| June 30, 2021 | -9.58% |
| March 31, 2021 | -9.51% |
| December 31, 2020 | 27.02% |
| September 30, 2020 | 11.22% |
| June 30, 2020 | -41.32% |
| March 31, 2020 | -17.64% |
| December 31, 2019 | 24.12% |
| September 30, 2019 | 11.38% |
| June 30, 2019 | -75.68% |
| March 31, 2019 | -13.04% |
| December 31, 2018 | 16.73% |
| September 30, 2018 | -4.75% |
| June 30, 2018 | -24.46% |
| March 31, 2018 | -42.49% |
| December 31, 2017 | 1.23% |
| Date | Value |
|---|---|
| September 30, 2017 | -37.92% |
| June 30, 2017 | -14.09% |
| March 31, 2017 | -104.5% |
| December 31, 2016 | -37.51% |
| September 30, 2016 | -61.08% |
| June 30, 2016 | -23.74% |
| March 31, 2016 | -25.87% |
| December 31, 2015 | -31.84% |
| September 30, 2015 | -39.05% |
| June 30, 2015 | -15.84% |
| March 31, 2015 | -44.82% |
| December 31, 2014 | -16.12% |
| September 30, 2014 | -71.62% |
| June 30, 2014 | -104.6% |
| March 31, 2014 | |
| December 31, 2013 | -36.45K% |
| September 30, 2013 | |
| June 30, 2013 | -163.0K% |
| March 31, 2013 | -69.30K% |
| December 31, 2012 | -35.00K% |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | -472.8K% |
| December 31, 2011 | |
| September 30, 2011 | -21.49K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-75.68%
Minimum
Jun 2019
27.02%
Maximum
Dec 2020
-7.98%
Average
-9.58%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
| Arbutus Biopharma Corp | -900.3% |
| Chimerix Inc | -454.0K% |
| Karyopharm Therapeutics Inc | -124.0% |
| Axsome Therapeutics Inc | -137.9% |
| Y-mAbs Therapeutics Inc | -4.23% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.57% |
| Return on Assets | -1.05% |
| Return on Invested Capital | -1.57% |
| Gross Profit Margin (Quarterly) | 74.63% |
| Operating Margin (Quarterly) | 19.59% |
| Return on Net Operating Assets | -2.09% |